Xun Zhu
Director/Board Member bei SIHUAN PHARMACEUTICAL HOLDINGS GROUP LTD.
Vermögen: 850 008 $ am 31.03.2024
Aktive Positionen von Xun Zhu
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| SIHUAN PHARMACEUTICAL HOLDINGS GROUP LTD. | Director/Board Member | 20.02.2014 | - |
| Independent Dir/Board Member | 20.02.2014 | - | |
| SHENZHEN CHIPSCREEN BIOSCIENCES CO., LTD. | Director/Board Member | 24.03.2018 | - |
| Independent Dir/Board Member | 24.03.2018 | - | |
| LANSEN PHARMACEUTICAL HOLDINGS LIMITED | Director/Board Member | 23.09.2022 | - |
| Independent Dir/Board Member | 23.09.2022 | - | |
| HIGHTIDE THERAPEUTICS, INC. | Director/Board Member | 30.11.2020 | - |
| Cathay International Pharmaceutical Ltd. | Director/Board Member | 01.08.2011 | - |
| China Medicinal Biotech Association | Corporate Officer/Principal | - | - |
| Norman Bethune Medical University | Corporate Officer/Principal | 01.01.1995 | - |
| National Natural Science Foundation of China | Corporate Officer/Principal | - | - |
Karriereverlauf von Xun Zhu
Ehemalige bekannte Positionen von Xun Zhu
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| Jilin University | Corporate Officer/Principal | 01.08.1994 | 01.06.2018 |
| ░░░░░░░░░░░ ░░░░ ░░░░░░░ ░░░░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - | - |
| ░░░░░░░░░░░ ░░░░░░░░░ ░░░░░░ | - | - |
Ausbildung von Xun Zhu
| Norman Bethune Medical University | Doctorate Degree |
Statistik
International
| China | 8 |
| Cayman Islands | 3 |
Operativ
| Director/Board Member | 6 |
| Independent Dir/Board Member | 4 |
| Corporate Officer/Principal | 4 |
Sektoral
| Health Technology | 6 |
| Consumer Services | 3 |
| Government | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 4 |
|---|---|
| SIHUAN PHARMACEUTICAL HOLDINGS GROUP LTD. | Health Technology |
| SHENZHEN CHIPSCREEN BIOSCIENCES CO., LTD. | Health Technology |
| LANSEN PHARMACEUTICAL HOLDINGS LIMITED | Health Technology |
| HIGHTIDE THERAPEUTICS, INC. | Health Technology |
| Private Unternehmen | 4 |
|---|---|
| China Medicinal Biotech Association | |
| National Natural Science Foundation of China | Government |
| Cathay International Pharmaceutical Ltd. | |
Apollomics, Inc. (United States)
 Apollomics, Inc. (United States) BiotechnologyHealth Technology Apollomics, Inc. operates as a sciences oncology company. It is a biotechnology company focusing on the discovery and development of oncology therapies with the potential to be combined with other treatment options to harness the immune system and target specific molecular pathways to inhibit cancer. The company was founded by Sanjeev Gurunath Redkar and Guo-Liang Yu on May 21, 2015 and is headquartered in Foster City, CA. | Health Technology |
